| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/05/2004 | CN1493296A Hemsleya amabilis drip pill and its preparation method |
| 05/05/2004 | CN1493295A Oleanolic acid drip pill and its preparation method |
| 05/05/2004 | CN1493293A Cefathiamidine freeze dried agent and its preparation method |
| 05/05/2004 | CN1493278A Silymarin behenic acid glyceride lipid nano particle oral solution dosage and its preparation method |
| 05/05/2004 | CN1493277A Rare earth hetero poly acid salt kind antigrip virus medicine and its synthesis method |
| 05/05/2004 | CN1148450C Recombinant proteinse of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 05/05/2004 | CN1148449C Mutants of streptococcal toxin C and methods of use |
| 05/05/2004 | CN1148447C Amino-terminally trancated RANTES as chemokine antagonists |
| 05/05/2004 | CN1148446C Polypeptide bound with MORT-1 and MACH and its DNA sequence, producing method, medical composition and use |
| 05/05/2004 | CN1148379C Antibiotic/antiendotoxic mimic peptide and its preparation and application |
| 05/05/2004 | CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 05/05/2004 | CN1148353C Phosphatidase A2 inhibitor and its prepn process and use |
| 05/05/2004 | CN1148352C 6.7-disubstituted-5,8-quinolinedione derivatives as antifungal agent |
| 05/05/2004 | CN1148225C Nano-level influenza virus splitting process to make subunit vaccine |
| 05/05/2004 | CN1148220C Antivirus antipyretic |
| 05/05/2004 | CN1148210C Exterior-applied Chinese-medicinal plaster for treating bone tuberculosis |
| 05/05/2004 | CN1148203C Medicine for treating onychomycosis |
| 05/05/2004 | CN1148168C Micronised pharmaceutical compositions |
| 05/04/2004 | US6730787 Viricides, immunostimulants, antitubercular, anticarcinogenic, antitumor, antidepressant, antichlamydial, and analgesic agents; psychological disorders |
| 05/04/2004 | US6730776 An antimicrobial compound produced by culturing and deacylating in the presence a microbial substance; used for treatment of infectious diseases caused by pathogenic microorganisms such as yeast or fungi |
| 05/04/2004 | US6730692 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 05/04/2004 | US6730683 Such as 1-cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors |
| 05/04/2004 | US6730682 Herpes virus |
| 05/04/2004 | US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/04/2004 | US6730661 Non-digestible dextrans, hydrolysed (galacto)mannans and/or hydrolysed (gluco)mannans; reduce the uptake of high molecular weight substances, allergens and microorganisms through the intestinal wall |
| 05/04/2004 | US6730486 Human βTrCP protein |
| 05/04/2004 | US6730480 Sphingosine kinase enzyme |
| 05/04/2004 | US6730296 Receptor agonists and antagonists |
| 05/04/2004 | US6730295 Anionic polymers as species specific antibacterial agents |
| 05/04/2004 | CA2201631C Liposome-formulations for treatment of viral diseases |
| 05/04/2004 | CA2120137C Feline leukemia virus vaccines |
| 05/04/2004 | CA2119756C Process for preparing benzo[b]naphtyridines |
| 04/29/2004 | WO2004036224A2 Screening method |
| 04/29/2004 | WO2004035777A1 Adipocyte differentiation-associated genes and proteins |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035598A2 Chalcomycin derivatives |
| 04/29/2004 | WO2004035590A2 Meso-substituted porphyrins |
| 04/29/2004 | WO2004035581A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/29/2004 | WO2004035062A1 Carbohydrate based anti-bacterials |
| 04/29/2004 | WO2004035032A2 Pharmaceutical formulations of camptothecine derivatives |
| 04/29/2004 | WO2004035021A2 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 04/29/2004 | WO2004035008A2 Treatment of infections and other disorders |
| 04/29/2004 | WO2004034957A2 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | WO2004034956A2 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 04/29/2004 | WO2004026303A3 Use of posaconazole for the treatment of fungal infections |
| 04/29/2004 | WO2004022092A3 Flagellin peptides as adjuvants for vaccines |
| 04/29/2004 | WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 04/29/2004 | WO2004017949A3 Prophylaxis and treatment of infectious diseases |
| 04/29/2004 | WO2004017940A3 Pharmaceutically active lipid based formulation of sn38 |
| 04/29/2004 | WO2004011402A3 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 04/29/2004 | WO2004006888A3 Stabilization of the profile of release of active substances from a formulation |
| 04/29/2004 | WO2004003185A3 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/29/2004 | WO2004000016A3 Antimicrobial compositions, products and methods employing same |
| 04/29/2004 | WO2003101996A8 Esters in position 20 of camptothecins |
| 04/29/2004 | WO2003095487A3 Immunogenic cd1 complexes |
| 04/29/2004 | WO2003074524A3 Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs |
| 04/29/2004 | WO2003065973A3 Multivalent streptococcal vaccine compositions and methods for use |
| 04/29/2004 | WO2003048187A3 Peptides and use thereof in therapeutic agents against hiv infection |
| 04/29/2004 | WO2003020949A3 Targeted nucleic acid constructs and uses related thereto |
| 04/29/2004 | WO2003009812A3 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 04/29/2004 | WO2003007986A8 Vaccine formulation potentiated by the combination of a dna and an antigen |
| 04/29/2004 | WO2003003004A3 Method for identifying compounds the specifically deplete mast cells |
| 04/29/2004 | WO2002102787A3 Novel sulfonic acid derivatives |
| 04/29/2004 | WO2002100417A8 Use of glycosaminoglycans for the treatment of hiv-associated nephropathy |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002070748A3 Response of dendritic cells to a diverse set of pathogens |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002043771A9 Conjugates of glycosylated/galactosylated peptide |
| 04/29/2004 | WO2002043651A8 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |
| 04/29/2004 | WO2002043649A8 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 04/29/2004 | WO2002020804A8 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses |
| 04/29/2004 | WO2002018341A8 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 04/29/2004 | WO2001082953A8 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040082796 Reacting a substituted benzonitrile with a cysteine compound |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082781 Bicyclic nitrogenous fused-ring compound |
| 04/29/2004 | US20040082757 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs |
| 04/29/2004 | US20040082664 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 04/29/2004 | US20040082643 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus |
| 04/29/2004 | US20040082640 Use of cox-2 inhibitors for preventing immunodeficiency |
| 04/29/2004 | US20040082638 Compounds, compositions and methods |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082630 1g(a)-Amino-n-hydroxy-acetamide derivatives |
| 04/29/2004 | US20040082614 Chlamydia infections; anticholesterol agents; cardiovascular disorders; using mixture containing azithromycin |
| 04/29/2004 | US20040082610 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor |
| 04/29/2004 | US20040082602 Kinase inhibitor; analgesics; antiarthritic agents; antihistamines; gastrointestinal disorders |
| 04/29/2004 | US20040082574 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flavivridae infections |
| 04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
| 04/29/2004 | US20040082562 Novel inhibitors of IMPDH enzyme |
| 04/29/2004 | US20040082555 Use of gaba, inverse agonists in combination with nicotine receptor partial agonist, estrogen, selective estrogen modulators, or vitamin E for the treatment of cognitive disorders |
| 04/29/2004 | US20040082553 Novel florfenicol-type antibiotics |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082549 Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections |
| 04/29/2004 | US20040082531 Containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that includes exon 1, but not intron A; use of such vectors in vaccine and pharmaceutical compositions and gene therapy |
| 04/29/2004 | US20040082527 Selected from the group of form D and E, F, G, J, M in the absence of azithromycin dihydrate, N, O, P, Q, and R; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of mammals, birds and fish; drug resistance |
| 04/29/2004 | US20040082526 11,12 gamma lactone ketolides and pharmaceutically acceptable salts and solvates thereof, for use in therapy or prophylaxis of systemic or topical bacterial infections in humans or animals |
| 04/29/2004 | US20040082524 Use of aivlosin, 3-O-acetyl-4''-O-isovaleryl-tylosin and pharmacologically acceptable derivatives; treatment of necrotic enteritis in poultry and Lawsonia infections, Mycoplasma diseases and swine dysentery in pigs |